OncologySTAT, a subscription-free professional oncology portal from STM publisher Elsevier, Netherlands, celebrated its one-year anniversary by releasing a list of the most influential oncology developments of the past year chosen by an expert physician panel. Two overriding themes of this online editorial feature are biomarker-directed treatment decisions and the growing clinical role of personalised medicine.
OncologySTAT's expert panel includes 12 of the most influential names in hematology and oncology. This includes two past-presidents of the American Society of Clinical Oncology (ASCO). Based on their expertise and experience, this distinguished group identified the developments with the greatest potential for shaping the future direction of oncology.
Oncologists turn to OncologySTAT to find scientific evidence on new and emerging developments such as biomarker-directed treatment. The top stories of the year selected by OncologySTAT's expert advisors illustrate the high level of scientific research within the oncology community, as well as the importance of OncologySTAT as a convenient, free online resource for the best available oncology journals and articles.
In June 2008, OncologySTAT commemorated its 12,000th registered user. Backed by the support of major healthcare and pharmaceutical companies, the site has emerged as one of the most trusted and trafficked professional websites in the growing field of cancer care. It has secured more than 16,000 registrants since its launch in September 2007 and has successfully captured more than 30 percent of US oncologists and hematologists as they actively seek clinical oncology information online.
More News in this Theme
